The P/E ratio for Amphastar Pharmaceuticals stock stands at 14.74 as of Apr 29, 2024. This is calculated based on the current EPS of $2.85 and the stock price of $42.02 per share. A decrease of 31% has been recorded in the PE ratio compared to the average of 21.3 of the past four quarters.
Over the last nine years, the average PE ratio of Amphastar Pharmaceuticals has been 148.56. The current 14.74 price-to-earnings ratio is 90% less than the historical average. In the past nine years, AMPH's PE ratio reached its highest point in the Mar 2016 quarter at 1,200, with a price of $12 and an EPS of $0.01. The Mar 2020 quarter saw the lowest point at 13.37, with a price of $14.84 and an EPS of $1.11.
Maximum annual increase: 3,513.64% in 2020
Maximum annual decrease: -97.33% in 2021
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 21.7 | 45.64% |
| 2022 | 14.9 | -16.85% |
| 2021 | 17.92 | -97.33% |
| 2020 | 670.33 | 3,513.64% |
| 2019 | 18.55 | N/A |
| 2018 | N/A | N/A |
| 2017 | 240.5 | 187.23% |
| 2016 | 83.73 | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
Currently, AMPH's PE ratio is lower than the 3 and 5-year averages.
When compared to its peer stock SCYX, AMPH's PE ratio is higher.
| Stock name | PE ratio | Market cap |
|---|---|---|
| SCYX Scynexis Inc | 1.21 | $64.18M |
| AMPH Amphastar Pharmaceuticals Inc | 14.47 | $1.98B |
| RGLS Regulus Therapeutics Inc | N/A | $151.55M |
| MRNS Marinus Pharmaceuticals Inc | N/A | $76.5M |
The price to earnings ratio for AMPH stock is 14.74 as of Apr 29, 2024.
The average PE ratio for AMPH stock over the past 3 years is 26.56.
The average PE ratio for AMPH stock over the past 5 years is 88.75.
The highest quarterly PE ratio in the last nine years has been 1,200 and it was in the Mar 2016 quarter.
The current price to earnings ratio of AMPH is 90% lower than the 9-year historical average.
The P/E ratio is calculated by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Apr 29, 2024), Amphastar Pharmaceuticals's stock price is $42.02. The earnings per share for the trailing twelve months (TTM) ending Dec 2023 is $2.85. Therefore, Amphastar Pharmaceuticals's price to earnings ratio for today is 14.74. PE RATIO(14.74) = STOCK PRICE($42.02) / TTM EPS($2.85)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.